Point72 Middle East FZE’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,016
Closed -$18K 1814
2023
Q3
$18K Buy
+1,016
New +$37K ﹤0.01% 1320
2023
Q1
Sell
-311
Closed -$18.8K 2097
2022
Q4
$18.8K Buy
+311
New +$28.9K ﹤0.01% 1645

Other funds holding RBOT

Point72 Middle East FZE's RBOT Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 1,016 shares — an estimated $18K sold.

Point72 Middle East FZE first reported a position in RBOT in Q4 2022 and held it in 2 quarters. The position peaked at $18.8K in Q4 2022. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 1,016 Vicarious Surgical shares in Q4 2023, an estimated $18K.
  • Point72 Middle East FZE first reported a position in Vicarious Surgical in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Vicarious Surgical position peaked at $18.8K in Q4 2022.
  • 72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.